Oculis Holding AG (OCS) Short-term Investments (2023 - 2026)
Oculis Holding AG (OCS) recorded quarterly Short-term Investments of $201.1 million in Q1 2026, up 22.05% quarter-over-quarter from $164.8 million in Q4 2025, and up 48.13% on a YoY basis from $135.8 million in Q1 2025.
Oculis Holding AG (OCS) Short-term Investments (2023 - 2026) Analysis & Trends
Oculis Holding AG's Short-term Investments history runs 4 years deep, the most recent figure standing at $201.1 million for Q1 2026.
- In Q1 2026, Short-term Investments rose 48.13% year-over-year to $201.1 million; the TTM figure through Mar 2026 stood at $201.1 million (up 48.13% YoY), while the FY2025 annual figure was $164.8 million, up 103.41% from the prior year.
- Short-term Investments was $201.1 million for Q1 2026 at Oculis Holding AG, up from $164.8 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $201.1 million in Q1 2026 to a low of $60.1 million in Q4 2023.
- Historically, Short-term Investments has averaged $106.2 million across 4 years, with a median of $83.9 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Short-term Investments declined 6.15% in 2024, then soared 113.22% in 2025.
- A 4-year view of Short-term Investments shows it stood at $60.1 million in 2023, then soared by 34.74% to $81.0 million in 2024, then jumped by 103.41% to $164.8 million in 2025, then rose by 22.05% to $201.1 million in 2026.
- The last three Short-term Investments figures came in at $201.1 million (Q1 2026), $164.8 million (Q4 2025), and $123.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 201.09 Mn |
| Dec 31, 2025 | 164.76 Mn |
| Sep 30, 2025 | 123.44 Mn |
| Jun 30, 2025 | 116.00 Mn |
| Mar 31, 2025 | 135.76 Mn |
| Dec 31, 2024 | 81.00 Mn |
| Sep 30, 2024 | 80.61 Mn |
| Jun 30, 2024 | 81.91 Mn |
| Mar 31, 2024 | 63.67 Mn |
| Dec 31, 2023 | 60.12 Mn |
| Sep 30, 2023 | 85.90 Mn |
| Jun 30, 2023 | 80.16 Mn |